Patients Rising Now Issues Statement on E&C IRA Hearing
FOR IMMEDIATE RELEASE Contact: Summer Johnson September 21, 2023 sjohnson@riesterinfluence.com PATIENTS...Read more
Federal Issues
Read more
Wilcox: MedPAC’S Part B Recommendations Threaten Patient Access to Care
FOR IMMEDIATE RELEASE April 13, 2023 Contact: Sarah Shelson sshelson@riesterpublicaffairs.com WASHINGTON — Patients Rising Now CEO and Co-founder Terry Wilcox today released the following statement regarding MedPAC’s recommendation to modify reimbursements for...Read more
Why We Need Patient Diversity in Clinical Trials
By Surabhi Dangi-Garimella, PhD Diversity presents facts. Diversity provides a true reflection of reality, and this holds true for clinical trials as well. The FDA’s Office of Minority Health and Health Equity is a big proponent of diversity among clinical trial...Read more
MDUFA Up for Renewal, Congress Recommends a Facelift
By Surabhi Dangi-Garimella, PhD User fee agreements—whether for a medical device or a prescription drug—create a path for manufacturers to get their product reviewed in a systematic manner by the FDA. The Medical Device User Fee and Modernization Act of 2002, known as...Read more
Season 3 | Episode 8: Speedy Rare Disease Drug Reviews
On this episode of the podcast, Terry and Bob discuss accelerated drug review for rare diseases. This topic coincides with Rare Disease Day on February 28. With the Prescription Drug User Fee Act (PDUFA) up for renewal in Congress, much is at stake for the rare...Read more
Telehealth Policies Needed to Address America’s Digital Healthcare Divide
By Surabhi Dangi-Garimella, PhD The 21st Century Cures Act is being rekindled: introduced in Congress in November 2021, CURES 2.0 proposes to upgrade several areas of the U.S. healthcare system, one of which is telehealth. The Telehealth Modernization Act includes...Read more